Synlett 1990; 1990(11): 681-683
DOI: 10.1055/s-1990-21210
letter
© Georg Thieme Verlag, Rüdigerstr. 14, 70469 Stuttgart, Germany. All rights reserved. This journal, including all individual contributions and illustrations published therein, is legally protected by copyright for the duration of the copyright period. Any use, exploitation or commercialization outside the narrow limits set by copyright legislation, without the publisher's consent, is illegal and liable to criminal prosecution. This applies in particular to photostat reproduction, copying, cyclostyling, mimeographing or duplication of any kind, translating, preparation of microfilms, and electronic data processing and storage.

Bridged Oxacephems; Part 1. Synthesis of 7α-[(R)-1-Hydroxyethyl]-2β,7β-ethano-1-oxacephems1,2

Masayuki Murakami* , Munenori Matsuura, Tsutomu Aoki, Wataru Nagata
  • *Shionogi Research Laboratories, Shionogy & Co., Ltd., Fukushima-ku, Osaka 553, Japan
Further Information

Publication History

Publication Date:
08 March 2002 (online)

Highly strained, bridged oxacephem molecules with the thienamycin-type [(R)-1-hydroxyethyl] side chain at 7α, 4 and 5, were designed as possible β-lactam antibiotics. Among them, two ethano-bridged compounds, i.e. 2β,7β-ethano-1-oxacephem 18 and its N-acetylcysteaminyl derivative 21, were successfully synthesized. X-ray crystallography showed that the distortion in the oxacephem moiety was comparable to the penicillin nucleus as indicated by the h value of 0.40 Å. As suggested by this value, the antibacterial activity of 21 was very weak.